Mobile Smoking Cessation Services (Mscs) To Achieve Smokefree Workplaces

MOBILE SMOKING CESSATION SERVICES (MSCS) TO ACHIEVE SMOKEFREE WORKPLACES Zaswiza MN* , M Haniki NM*, M Aznan MA**, Samsul D**, S Halimah Bux*, N Syafinaz AR*. * KULLIYYAH OF PHARMACY, INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA, PAHANG. ** KULLIYYAH OF MEDICINE, INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA, PAHANG.

Background ,[object Object],[object Object],[object Object],[object Object],[object Object],QUIT SMOKING CLINICS MEDIA

[object Object],[object Object],WORKPLACES INTERVENTION :

[object Object],[object Object],[object Object],To our knowledge, this is the first mobile smoking cessation service ever established in Malaysia.

OBJECTIVES OF STUDY ,[object Object]

INTRODUCTION ,[object Object],[object Object],[object Object],[object Object]

The flow of mobile smoking cessation programme ,[object Object],[object Object],[object Object],[object Object],[object Object],Motivational talk and counselling at baseline Screening and baseline tests Self-administered demographic and smoking history data Booklets : record daily no. of cigarettes smoked and withdrawal (1)

RANDOMIZATION: RANDOMIZED DOUBLE BLIND PLACEBO CONTROL TRIAL 2 GROUPS : PHARMACOTHERAPY VS. PLACEBO n = 75 n = 72 (2)

(3) FOLLOW-UP : WEEK 2 (4) FOLLOW-UP : WEEK 4 “ QUIT DATE” ,[object Object],[object Object]

(5) FOLLOW-UP WEEK 12 OR Face-to –face interview / counselling Plus CO test ( in addition to self-reported smoking status) Telephone interview / counselling NO CO test (self-reported smoking status)

(6) Final follow-up week 24 (6 Months) ,[object Object],[object Object],[object Object],Taking and preparing urine and saliva samples Detection of cotinine in saliva using Saliva NicAlert® dipstick. CO test in addition to cotinine detection tests using PiCO + smokerlyzer. Detection of cotinine in urine samples : HPLC – UV analysis .

[object Object],201 (attended programmes), 4 (personal interviews) = TOTAL (205) Eligible , but chose not to enrol (n=50) Placebo + counselling (n=78) Viva QS® + counselling (n=77) Wk 2: F/up (n=73) Missed F/up (3), w/drew (1) a Wk 2: F/up (n=71) Missed F/up (7) Wk 12: F/up (n=73) Missed F/up (3) Wk 4: F/up (n=73) Missed F/up (3) Wk 4: F/up (n=67) Missed F/up (8), Drop outs (3) b Wk 24: F/up (n=73) Missed F/up (3) c Wk 24: F/up (n=68) Missed F/up (7) c Wk 12: F/up (n=67) Missed F/up (8) Met inclusion criteria and enrol (n=155 ) Randomised to group Completion of study: Viva QS® (N=75) Placebo(N=72)

[object Object],[object Object],[object Object],[object Object],[object Object]

CHARACTERISTICS OF SMOKERS AT BASELINE b n = 144. Three (3) subjects with missing data. * Total n = 147 Characteristics n (%) * Age (years) 18-30 52 (35.4) 31-45 71 (48.3) 46-60 24 (16.3) Race Malay 145 (98.6) Others 2 (1.4) Marital status b Married 125 (86.8) Never married or divorced 19 (13.2) Education Secondary school 42 (28.6) Certificate 20 (13.6) Degree/ Diploma 85 (57.8)

CHARACTERISTICS OF SMOKING HISTORY AT BASELINE a The FTND is a validated 6-items instrument to measure the level of dependence to nicotine. The total score range is 0 to 10, with ≥6 indicating high dependence . Characteristics n (%) Age begin smoking (years), n (%) 10-15 41 (27.9) 16-20 87 (59.2) 21-40 19 (12.9) Current tobacco use (No. of cigarette smoked per day), n (%) 1-10 sticks 35 (23.8) 11-20 sticks 91 (61.9) > 20 sticks 21 (14.3) Mean (SD) Carbon monoxide (CO) level (ppm) 11.50 (4.564) Modified Fagerstrom test score for nicotine dependence (FTND) a 5.03 (1.394)

7-days prevalence abstinence at week 24 * P < o.o5 QUITTERS , n(%) SMOKERS, n(%) P Value (Pearson Chi-square) OR (95% CI) 33 (22.4) 114 (77.6) 0.015 * 2.74 (1.20-6.28) Viva QS Placebo Viva QS Placebo 23 (30.7) 10 (13.9) 52 (69.3) 62 (86.1)

7-days prevalence abstinence at week 4 and week 12 * P < 0.05 QUITTERS, n(%) SMOKERS, n(%) P Value (Pearson Chi-square) OR (95% CI) Week 4 51 (34.7) 96 (65.3) 0.038 * 2.08 (1.04-4.16) Viva QS Placebo Viva QS Placebo 32 (42.7) 19 (26.2) 43 (57.3) 53 (73.6) Week 12 36 (24.5) 111 (75.5) 0.031* 2.35 (1.07-5.17) Viva QS Placebo Viva QS Placebo 24 (32.0) 12 (16.7) 51 (68.0) 60 (83.3)

[object Object],[object Object],[object Object],[object Object]

Mobile Smoking Cessation Services (Mscs) To Achieve Smokefree Workplaces

Recomendados

Recomendados

Mais conteúdo relacionado

Mais procurados

Mais procurados (12)

Destaque

Destaque (20)

Semelhante a Mobile Smoking Cessation Services (Mscs) To Achieve Smokefree Workplaces

Semelhante a Mobile Smoking Cessation Services (Mscs) To Achieve Smokefree Workplaces (20)

Último

Último (20)

Mobile Smoking Cessation Services (Mscs) To Achieve Smokefree Workplaces